NCT07405086
- Conditions
- Adenocarcinoma, Advanced Biliary Tract Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +63 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Clinical trial condition
Metastatic Hepatocellular Carcinoma
Explore clinical trials studying Metastatic Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
27 public trials
13 recruiting studies
Metastatic Hepatocellular Carcinoma trial results
NCT05003895
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07174570
- Conditions
- Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +12 more
- Locations
-
- Grady Health System Atlanta, Georgia, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
Not yet recruiting
Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver Cancer
NCT07716345
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
Not specified
Not yet recruiting
Peritumoral MRE Stiffness for Predicting Resection Margin Status and Recurrence in Liver Cancer
NCT07704216
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
Not specified
Not yet recruiting
Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing Hepatectomy
NCT07704203
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
Not specified
Active, not recruiting
Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma
NCT03937830
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, not recruiting
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
NCT04175912
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Active, not recruiting
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors
NCT05075993
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
NCT04514484
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States